Today: 29 April 2026
Browse Category

OTCMKTS:NKLAQ 6 December 2025

Nikola Corp (NKLAQ) Stock in December 2025: Bankruptcy, Liquidation and What’s Next for Shareholders

Nikola Corp (NKLAQ) Stock in December 2025: Bankruptcy, Liquidation and What’s Next for Shareholders

Nikola Corporation’s stock, now trading as NKLAQ over the counter, is priced near $0.0026 after losing nearly all value in the past year. A court-approved liquidation plan set for December 2025 will cancel all common shares with no recovery for shareholders. Trading is thin and highly restricted. Nikola has ceased operations and is in bankruptcy.
6 December 2025
··

Stock Market Today

  • John Hancock Multifactor Small Cap ETF (JHSC) Sees Unusual Volume Spike
    April 29, 2026, 1:20 PM EDT. The John Hancock Multifactor Small Cap ETF (JHSC) experienced an unusual surge in trading volume Wednesday afternoon, with over 732,000 shares changing hands versus its typical three-month average of 27,000. Despite heightened activity, JHSC shares dipped 0.8% on the day. Key components driving volume included Mara Holdings, which fell 6.3% on a hefty 16.8 million shares traded, and Transocean, down 0.4% on 12.4 million shares. Vita Coco led gains within the ETF, surging 20.4%, while Siteone Landscape Supply struggled, shedding 17.2%. The wide swings among key holdings highlight the mixed sentiment within this small-cap multifactor ETF.

Latest article

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

29 April 2026
General Dynamics raised its 2026 profit outlook after first-quarter earnings and revenue topped estimates, sending shares up 10.9% to $347.72. The company reported $1.4 billion in operating earnings and $13.5 billion in revenue, with Marine Systems revenue up 21% on submarine programs. Orders reached $26.6 billion, pushing backlog to $130.8 billion. General Dynamics ended the quarter with $3.7 billion in cash.
Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Teva reported first-quarter adjusted earnings of 53 cents per share on $3.98 billion revenue, beating estimates as sales of Austedo, Ajovy, and Uzedy climbed. Shares jumped 11% in New York trading. The company agreed to buy Emalex Biosciences for $700 million upfront, adding a late-stage Tourette syndrome drug candidate. Global generics revenue fell 16% amid increased competition.
Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

29 April 2026
Silicon Motion reported first-quarter revenue of $342.1 million, up 105% from a year earlier, and forecast second-quarter sales above Wall Street estimates. Shares rose $45.09 to $194.27 in New York trading. The company cited strong demand for embedded storage controllers and AI-related enterprise storage. CEO Wallace Kou said its MonTitan SSD controller platform will enter volume production this quarter.
Go toTop